A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults.

Saved in:
Bibliographic Details
Title: A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults.
Authors: Tiono AB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Plieskatt JL; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark., Ouedraogo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Soulama BI; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Miura K; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Bougouma EC; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Naghizadeh M; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Barry A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Yaro JBB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Ezinmegnon S; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Henry N; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Ofori EA; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Adu B; Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Accra, Ghana., Singh SK; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Konkobo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Lövgren Bengtsson K; Novavax AB, Uppsala, Sweden., Diarra A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Carnrot C; Novavax AB, Uppsala, Sweden., Reimer JM; Novavax AB, Uppsala, Sweden., Ouedraogo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Tienta M; Malaria Research and Training Center, Mali-National Institute of Allergy and Infectious Diseases International Center for Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali., Long CA; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Ouedraogo IN; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Sagara I; Malaria Research and Training Center, Mali-National Institute of Allergy and Infectious Diseases International Center for Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali., Sirima SB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Theisen M; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Source: The Journal of clinical investigation [J Clin Invest] 2024 Apr 01; Vol. 134 (7). Date of Electronic Publication: 2024 Apr 01.
Publication Type: Clinical Trial, Phase I; Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-8238
DOI:10.1172/JCI175707